The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

European Union Approves Merck's Hepatitis C Drug Victrelis

July 20, 2011

Merck & Co. said Monday that EU regulators have approved its drug Victrelis (boceprevir). The drug is administered along with standard combination therapy to treat hepatitis C; the approval is for use in treatment-naive patients as well as those who have failed on other regimens. Victrelis now can be marketed in all 27 EU countries. US regulators approved Victrelis on May 13.

Back to other news for July 2011

Adapted from:
Associated Press

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More News and Research on Victrelis (Boceprevir)

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: